ABBV
Price
$271.45
Change
+$4.76 (+1.78%)
Updated
Oct 7, 11:01 AM (EDT)
Capitalization
470.55B
23 days until earnings call
Intraday BUY SELL Signals
JNJ
Price
$259.95
Change
+$5.17 (+2.03%)
Updated
Oct 7, 11:06 AM (EDT)
Capitalization
655.37B
6 days until earnings call
Intraday BUY SELL Signals
MRK
Price
$143.09
Change
+$1.16 (+0.82%)
Updated
Oct 7, 11:07 AM (EDT)
Capitalization
366.84B
22 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ABBV or JNJ or MRK

ABBV vs JNJ vs MRK Comparison Chart in %
View a ticker or compare two or three
Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
ABBV vs JNJ vs MRK: Fundamental Ratings
ABBV
JNJ
MRK
OUTLOOK RATING
1..100
905769
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
12
Undervalued
11
Undervalued
PROFIT vs RISK RATING
1..100
4633
SMR RATING
1..100
13779
PRICE GROWTH RATING
1..100
554942
P/E GROWTH RATING
1..100
76102
SEASONALITY SCORE
1..100
505050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MRK's Valuation (11) in the Pharmaceuticals Major industry is in the same range as JNJ (12) and is in the same range as ABBV (16). This means that MRK's stock grew similarly to JNJ’s and similarly to ABBV’s over the last 12 months.

ABBV's Profit vs Risk Rating (4) in the Pharmaceuticals Major industry is in the same range as JNJ (6) and is in the same range as MRK (33). This means that ABBV's stock grew similarly to JNJ’s and similarly to MRK’s over the last 12 months.

ABBV's SMR Rating (1) in the Pharmaceuticals Major industry is somewhat better than the same rating for JNJ (37) and is significantly better than the same rating for MRK (79). This means that ABBV's stock grew somewhat faster than JNJ’s and significantly faster than MRK’s over the last 12 months.

MRK's Price Growth Rating (42) in the Pharmaceuticals Major industry is in the same range as JNJ (49) and is in the same range as ABBV (55). This means that MRK's stock grew similarly to JNJ’s and similarly to ABBV’s over the last 12 months.

MRK's P/E Growth Rating (2) in the Pharmaceuticals Major industry is in the same range as JNJ (10) and is significantly better than the same rating for ABBV (76). This means that MRK's stock grew similarly to JNJ’s and significantly faster than ABBV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABBVJNJMRK
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
33%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
54%
Bullish Trend 1 day ago
65%
Momentum
ODDS (%)
Bullish Trend 1 day ago
61%
Bearish Trend 1 day ago
49%
Bearish Trend 1 day ago
50%
MACD
ODDS (%)
Bearish Trend 1 day ago
45%
Bearish Trend 1 day ago
43%
Bearish Trend 1 day ago
52%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
63%
Bearish Trend 1 day ago
40%
Bearish Trend 1 day ago
49%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
64%
Bearish Trend 1 day ago
44%
Bearish Trend 1 day ago
42%
Advances
ODDS (%)
Bullish Trend 1 day ago
61%
Bullish Trend 10 days ago
47%
Bullish Trend 16 days ago
58%
Declines
ODDS (%)
Bearish Trend 7 days ago
46%
Bearish Trend 3 days ago
40%
Bearish Trend 7 days ago
51%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
54%
Bullish Trend 1 day ago
47%
Bullish Trend 1 day ago
69%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
38%
Bullish Trend 1 day ago
62%
COMPARISON
Comparison
Oct 07, 2026
Stock price -- (ABBV: $266.69, JNJ: $254.78, MRK: $141.94)
Brand notoriety: ABBV, JNJ and MRK are all notable
The three companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: ABBV: 97%, JNJ: 84%, MRK: 80%
Market capitalization -- ABBV: $470.55B, JNJ: $655.37B, MRK: $366.84B
$ABBV is valued at $470.55B, while JNJ has a market capitalization of $655.37B, and MRK's market capitalization is $366.84B. The market cap for tickers in this @Pharmaceuticals: Major ranges from $4.8K to $1.06T. The average market capitalization across the @Pharmaceuticals: Major industry is $200.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABBV’s FA Score shows that 3 FA rating(s) are green while JNJ’s FA Score has 3 green FA rating(s), and MRK’s FA Score reflects 3 green FA rating(s).

  • ABBV’s FA Score: 3 green, 2 red.
  • JNJ’s FA Score: 3 green, 2 red.
  • MRK’s FA Score: 3 green, 2 red.
According to our system of comparison, JNJ is a better buy in the long-term than MRK, which in turn is a better option than ABBV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABBV’s TA Score shows that 5 TA indicator(s) are bullish while JNJ’s TA Score has 4 bullish TA indicator(s), and MRK’s TA Score reflects 4 bullish TA indicator(s).

  • ABBV’s TA Score: 5 bullish, 2 bearish.
  • JNJ’s TA Score: 4 bullish, 6 bearish.
  • MRK’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ABBV is a better buy in the short-term than MRK, which in turn is a better option than JNJ.

Price Growth

ABBV (@Pharmaceuticals: Major) experienced а +1.29% price change this week, while JNJ (@Pharmaceuticals: Major) price change was -4.78% , and MRK (@Pharmaceuticals: Major) price fluctuated -4.92% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -3.44%. For the same industry, the average monthly price growth was -6.51%, and the average quarterly price growth was +7.41%.

Reported Earning Dates

ABBV is expected to report earnings on Oct 30, 2026.

JNJ is expected to report earnings on Oct 13, 2026.

MRK is expected to report earnings on Oct 29, 2026.

Industries' Descriptions

@Pharmaceuticals: Major (-3.44% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

View a ticker or compare two or three
ABBV
Daily Signal:
Gain/Loss:
JNJ
Daily Signal:
Gain/Loss:
MRK
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NU15.660.48
+3.16%
Nu Holdings Ltd
AX89.030.52
+0.59%
Axos Financial
DLX22.54-0.13
-0.57%
Deluxe Corp
TRDA5.42-0.06
-1.09%
Entrada Therapeutics
GPUS0.16N/A
-1.64%
Hyperscale Data Inc.

ABBV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABBV has been loosely correlated with BMY. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ABBV jumps, then BMY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABBV
1D Price
Change %
ABBV100%
+0.35%
BMY - ABBV
50%
Loosely correlated
+1.33%
NVS - ABBV
49%
Loosely correlated
-0.10%
JNJ - ABBV
48%
Loosely correlated
+0.73%
AMGN - ABBV
48%
Loosely correlated
-0.09%
MRK - ABBV
43%
Loosely correlated
+1.72%
More

JNJ and

Correlation & Price change

A.I.dvisor indicates that over the last year, JNJ has been loosely correlated with PFE. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if JNJ jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JNJ
1D Price
Change %
JNJ100%
+0.73%
PFE - JNJ
59%
Loosely correlated
+0.33%
NVS - JNJ
50%
Loosely correlated
-0.10%
GSK - JNJ
49%
Loosely correlated
+0.11%
ABBV - JNJ
49%
Loosely correlated
+0.35%
MRK - JNJ
49%
Loosely correlated
+1.72%
More

MRK and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRK has been loosely correlated with GSK. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if MRK jumps, then GSK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRK
1D Price
Change %
MRK100%
+1.72%
GSK - MRK
52%
Loosely correlated
+0.11%
PFE - MRK
48%
Loosely correlated
+0.33%
BMY - MRK
48%
Loosely correlated
+1.33%
NVS - MRK
47%
Loosely correlated
-0.10%
JNJ - MRK
47%
Loosely correlated
+0.73%
More